Early activation antigen CD69 Inhibitors (IC50, Ki)

Name: Early activation antigen CD69 Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Structure ▲ ▼	Compound Name ▲ ▼	Standard Type ▲ ▼	Standard Values (in nM) ▲ ▼
	2-[[26,27,28-Tris(carboxymethoxy)-2,8,14,20-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaen-25-yl]oxy]acetic acid	IC50	0.65 ^[1], 0.71 ^[2], 12.59 ^[3], 15.0 ^[4]
	4-Tert-Butylcalix[4]arene tetraacetic acid	IC50	3.7 ^[1], 4.3 ^[2], 25.12 ^[3], 150.0 ^[4]
	2-[[17,25,27-Tris(carboxymethoxy)-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaenyl]oxy]acetic acid	IC50	14.0 ^[1], 21.0 ^[2], 50.12 ^[3], 1300.0 ^[4]
	2-Acetamido-2-deoxy-beta-D-glucopyranose	IC50	125892.54 ^[1], 316227.77 ^[2], 1000000.0 ^[3]
	Duvoglustat hydrochloride	IC50	630957.34 ^[1]
	2-(Acetylamino)-2-deoxy-alpha-D-mannopyranose	IC50	1000000000.0 ^[1]
	N-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-[[11,17,23-tris[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamothioylamino]-25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]carbamothioylamino]oxan-3-yl]acetamide	IC50	0.5 ^[1]
	2-[[5,11,17,23-Tetratert-butyl-26,27,28-tris(carboxymethoxy)-2,8,14,20-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaen-25-yl]oxy]acetic acid	IC50	398107.17 ^[1]
	4-[[11,17,23-Tris[(4-carboxyphenyl)diazenyl]-25,26,27,28-tetrahydroxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]diazenyl]benzoic acid	IC50	63.1 ^[1]
	2-[[11,23,26,28-Tetratert-butyl-17,25,27-tris(carboxymethoxy)-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]oxy]acetic acid	IC50	251188.64 ^[1]
	2-[[5,11,17,23-Tetratert-butyl-27-(carboxymethoxy)-26,28-dihydroxy-2,8,14,20-tetraoxo-2lambda4,8lambda4,14lambda4,20lambda4-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaen-25-yl]oxy]acetic acid	IC50	79432.82 ^[1]
	2-[[27-(Carboxymethoxy)-26,28-dihydroxy-2,8,14,20-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaen-25-yl]oxy]acetic acid	IC50	79.43 ^[1]
	2-[[26,27,28-Tris(carboxymethoxy)-25-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaenyl]oxy]acetic acid	IC50	31622.78 ^[1]
	[(2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-(triazol-1-yl)oxan-3-yl] acetate	IC50	3981.07 ^[1]
	N-[(2R,3S,4R,5R,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide	IC50	1000000000.0 ^[1]
	N-[(2R,3S,4R,5R,6R)-2-[(2R,3R,4R,5S)-4,5-Dihydroxy-2-(hydroxymethyl)piperidin-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide	IC50	501187.23 ^[1]
	N-[(2R,3S,4R,5S,6R)-2-[(2R,3R,4R,5S)-4,5-Dihydroxy-2-(hydroxymethyl)piperidin-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide	IC50	31622.78 ^[1]

Items per page: 1 - 10 of 17

⟨⟩

References

This online tool may be cited as follows

MLA	"Quest Database™ Early activation antigen CD69 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 10 May. 2024, https://www.aatbio.com/data-sets/early-activation-antigen-cd69-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2024, May 10). Quest Database™ Early activation antigen CD69 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/early-activation-antigen-cd69-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan

Location: Home / Datasets / Early activation antigen CD69 Inhibitors (IC50, Ki)

About Privacy Terms of Use Terms of Sales Distributors

Early activation antigen CD69 Inhibitors (IC50, Ki)

References

This online tool may be cited as follows

MLA

APA